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The atonal homolog 7 (ATOH7) gene encodes a transcription factor involved in determining the fate of retinal pro-
genitor cells and is particularly required for optic nerve and ganglion cell development. Using a combination of
autozygosity mapping and next generation sequencing, we have identified homozygous mutations in this gene,
p.E49V and p.P18RfsX69, in two consanguineous families diagnosed with multiple ocular developmental defects,
including severe vitreoretinal dysplasia, optic nerve hypoplasia, persistent fetal vasculature, microphthalmia,
congenital cataracts, microcornea, corneal opacity and nystagmus. Most of these clinical features overlap with
defects in the Norrin/b-catenin signalling pathway that is characterized by dysgenesis of the retinal and hyaloid
vasculature. Our findings document Mendelian mutations within ATOH7 and imply a role for this molecule in the
development of structures at the front as well as the back of the eye. This work also provides further insights into
the function of ATOH7, especially its importance in retinal vascular development and hyaloid regression.
INTRODUCTION
The development of the vertebrate retina has been extensively
studied as a simple and accessible model for neurogenesis.
This work has shown that the seven major retinal cell types
arise from a single population of progenitor cells through a
tightly controlled sequential program of migration and differ-
entiation (1). Basic helix-loop-helix (bHLH) transcription
factors homologous to Drosophila achaete-scute and atonal
have been shown to play key roles in specifying the neuronal
fate of these multipotent retinal progenitors (2). One of the
best characterized members of this family is ATOH7 (atonal
homolog 7 [MIM ∗609875]), also known as Math5 in the
mouse and Ath5 in other vertebrates.
ATOH7 is a single exon gene that encodes a 152-amino acid
protein with a bHLH domain spanning residues 41–96 (3).
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The basic motif (residues 41–52) is essential for specific
deoxyribonucleic acid (DNA) binding and the HLH domain
(residues 53–96) forms homo- or hetero-dimers with other
family members (4,5). It is one of the first transcription
factors to be expressed in retinal progenitor cells and this
expression coincides with the onset of neurogenesis (6).
Loss-of-function and over-expression experiments in animals
have shown that this protein is vital for retinal ganglion cell
(RGC) development (7–10), but is also associated with differ-
entiation of progenitors into photoreceptors, horizontal and
amacrine cells (11,12). Given the hierarchical nature of
retinal growth, with RGCs the first cell type to be specified,
we might expect that removal of this protein would grossly
disrupt eye development. However, studies in animal models
have shown this is not the case. For example, ATOH7-deficient
mice have normal sized eyes but have a .95% reduction in
RGC number, and lack an optic nerve and chiasm. They
also retain the overall retinal laminar structure though they
are slightly thinner as a result of ganglion cell loss, and
have an increased number of cone photoreceptors through a
switch in cell specification (7,8). Similarly, zebrafish with a
mutation in Ath5 have a comparable loss of RGCs and an
increase in amacrine, bipolar and Muller cells which are
consistent with cell fate differences in fish (9).
More recently, there has been increased interest in ATOH7
following several genome-wide association studies which
have implicated variants in this gene as significantly
associated with optic disc area (13–15) and open angle glau-
coma (16,17). However, to date no human disease phenotype
has been linked to Mendelian mutations within this gene. In
this report, we have used a combination of autozygosity
mapping and next generation sequencing to identify patients
with homozygous mutations in ATOH7, and widen the
reported role of this protein to include the development of
the hyaloid and retinal vasculature as well as the anterior
segment of the eye.
RESULTS
Clinical details and autozygosity mapping
We recruited and sampled a consanguineous family, MEP57,
from the Punjab province of Pakistan, with multiple affected
members that segregated dense corneal opacity, microphthal-
mia and microcornea (horizontal diameter , 11 mm) in a
recessive manner (Fig. 1A). Affected individuals also had nys-
tagmus and severely reduced visual function permitting per-
ception of light only. We have previously reported this
family and mapped the gene involved by autozygosity
mapping to a 36.8 Mb interval flanked by microsatellite
markers D10S1208 (35.3 Mb) and D10S676 (72.1 Mb) on
chromosome 10cen (Supplementary Material, Fig. S1) (18).
This family was initially assessed in a rural Pakistan village,
near Lahore, so examination of the posterior eye was not
Figure 1. Analysis of MEP57. (A) Pedigree structure for family MEP57. The individuals from whom DNA is available are numbered. (B) B-scan ultrasound
examination of the right (1) and left (2) eyes from patients 2298 (aged 33 years) and 2299 (aged 24 years). Note a reduced axial length (microphthalmia) together
with disorganization of the vitreous and chronic retinal detachments. (C) Sequence chromatograms highlighting the ATOH7 mutation in an affected patient from
MEP57 and the corresponding wild-type sequence from a normal individual. (D) Molecular modelling of the bHLH domain of human ATOH7 wild-type and
p.E49V. Ribbon representation of the bHLH domain in ATOH7 (in green) dimerized with the transcription factor E2-alpha (in grey) and bound to double-
stranded DNA (purple and orange helix) as a lateral (1) and, following a 908 rotation, frontal (2) view. Note residue E49 in the wild-type sequence is in
close connection with the DNA helix. The proximity of the E49 (3) and V49 (4) residues to the DNA helix shows that the V49 is more distant and so is
less likely to interact with the DNA.
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possible due to the severity of the anterior eye abnormalities.
However, several patients in the family have subsequently
undergone ultrasound examination of the eyes which showed
a retrolental mass consistent with severe dysplasia of the
retina and vitreous (Fig. 1B).
Next generation sequencing
Given that the number of genes located in the mapped locus is
nearly 160, we used a NGS approach to identify the pathogen-
ic mutation in family MEP57. A customized liquid-phase
target enrichment reagent was created to capture all the
coding exons and flanking splice sites within the critical
region. In total, 1490 of 1492 exons were covered, amounting
to 278 kb of DNA sequence. Only 201 bp of exonic sequence
could not be targeted due to homology with repetitive
sequences. Genomic DNA from patient 2298 (IV:2 in
Fig. 1A) was enriched using this reagent, and the resulting
library was sequenced on an Illumina GAIIx sequencer. The
processed sequencing files were aligned to the human refer-
ence sequence and polymerase chain reaction (PCR) dupli-
cates were removed. Before their removal, the mean depth
of coverage for targeted regions was 383 reads, but after dupli-
cate removal the mean depth amounted to 110 reads with base
phred quality scores of at least 17. In summary, 98% of the tar-
geted bases were covered by at least five reads with this
quality threshold. A total of 203 variants were detected
within the locus but after exclusion of all those annotated as
single nucleotide polymorphisms (SNPs) in dbSNP131 only
13 changes remained. Five were intronic (not splice site) var-
iants, three were synonymous and five were non-synonymous
variants. Of the five non-synonymous variants (Table 1), two
were considered to be non-pathogenic or artefactual, as they
were also identified in seven unrelated DNAs that were run
in a parallel experiment, leaving three potentially pathogenic
variants that were unique to MEP57; a homozygous G to
A nucleotide change in FRMPD2 (ferm and pdz
domains-containing protein 2 [MIM ∗613323]) that substitutes
an arginine for a glycine residue (c.1051G.A; p.G351R), a
homozygous A to T nucleotide change in ATOH7 that substi-
tutes a valine for a glutamic acid residue (c.146A.T; p.E49V;
Fig. 1C) and a homozygous G to T nucleotide change in PBLD
(phenazine biosynthesis-like protein domain-containing
protein [MIM ∗612189]) that substitutes an isoleucine for a
serine residue (c.185G.T; p.S62I).
Segregation of each potentially pathogenic missense variant
with the disease phenotype was confirmed by direct sequen-
cing in all available family members. We then sequenced
the variants in a cohort of 170 ethnically matched control indi-
viduals (340 chromosomes). The FRMPD2 variant was
present in three control DNAs (and has now been entered
into dbSNP132) and was therefore excluded as a pathogenic
mutation. The ATOH7 and PBLD variants were not present
in the control panel and were therefore assessed for functional
impact with the PolyPhen-2 algorithm. Using a HumVar
model, scores of 0.758 and 0.985 predicted that both variants
were possibly damaging. However, alignment of orthologous
protein sequences reveals that the E49 residue in ATOH7 is
fully conserved, while the S62 residue in PBLD is conserved
through mammals and birds but not in zebrafish (Danio
rerio) and worm (Caenorhabditis elegans) (Supplementary
Material, Fig. S2). The E49 residue lies within the basic
motif of the bHLH domain that is responsible for binding
the transcription factor to DNA at the consensus hexanucleo-
tide sequence known as the E box (19). In silico modelling
shows that the missense mutation is likely to prevent DNA
binding and abolish transcription factor activity (Fig. 1D).
Screening for further mutations by direct sequencing
ATOH7 is predominantly expressed in the eye and has a well-
documented role in eye development, while PBLD is a ubiqui-
tously expressed putative hydroxylase with no known function
in the eye (20). This together with evolutionary conservation
pointed to ATOH7 E49V as the causative mutation in family
MEP57. We therefore screened ATOH7 in a cohort of 93
patients with anterior segment dysgenesis by direct sequen-
cing. Since the observed phenotype in MEP57 included both
anterior (corneal opacity and microcornea) and posterior
(vitreoretinal dysplasia) segment abnormalities, a further 12
patients with retinal dysplasia or severe familial exudative
vitreoretinopathy (FEVR) were also screened. A homozygous
1 bp deletion of a C nucleotide in the coding sequence of
ATOH7 that created a frameshift and premature protein
Table 1. Summary of the non-synonymous variants identified following targeted capture and next generation sequencing for MEP57 (2298; IV.2)
CHROM: POS REF MEP57 Gene cDNA, protein Exon Frequency in controls Evolutionarily conserveda
chr10:49440275 G A FRMPD2 c.1051G.A, p.G351R 10 3/340 chromosomes NA
chr10:51768674 CAA Cb AGAP6 c.790_791del, p.K264RfsX10 NA Not determined NA
chr10:62547870 T T/Gc CDC2 c.371T.G, p.V124G NA Not determined NA
chr10:69991289 A T ATOH7 c.146A.T, p.E49V 1A 0/340 chromosomes Yes
chr10:70056121 G T PBLD c.185G.T, p.S62I 4 0/340 chromosomes No
The variants remaining after filtering against dbSNP131 are summarized. The chromosome and the position of the variant in base pairs based on the UCSC
Genome Browser hg19 (CHROM: POS), reference sequence at this position (REF), MEP57 sequence at this position (MEP57), gene ID, cDNA and protein
sequence for the variation, the exon harbouring the variant (the corresponding primer pairs for PCR amplification and direct DNA sequencing are depicted in
Supplementary Material, Table S1), the frequency of the variant in ethnically matched control DNAs and whether the normal amino acid residue at the position of
the variation is evolutionarily conserved are shown.
NA, not applicable; b and c likely represent false positives as b was detected in 2/7 and c detected in 7/7 unrelated DNAs that were processed with the same
enrichment reagent.
aEvolutionary conservation is illustrated in Supplementary Material, Figure S2.
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truncation (c.53delC; p.P18RfsX69) was identified in a con-
genital blind brother and sister from Turkey who were born
to healthy consanguineous parents (Fig. 2). Segregation of
this mutation was confirmed in the family and it was excluded
from 170 ethnically matched control DNAs. The PBLD gene
was also screened for mutations in this family but none were
found.
Clinical examination of these patients revealed corneal opaci-
ties, microphthalmia, nystagmus, bilateral retinal detachments
and vitreous degenerations, as in MEP57, but also cataracts, per-
sistent fetal vasculature, hypoplastic optic nerves and calcifica-
tions present on the hyaloid membranes, retina and in the
vitreous. The clinical phenotype was considered similar to that
observed in Norrie disease (MIM #310600), but pedigree struc-
ture ruled out an X-linked condition. Both children had no
microcephaly or mental retardation and no hearing problems, al-
though the younger child made some sterotypic movements of
the head. Fluorescein angiography examination of both
parents showed no abnormalities. The patients were therefore
given a diagnosis of recessive FEVR.
DISCUSSION
Here we report the identification of recessive human mutations
within ATOH7 in two families with global eye developmental
defects comprising severe vitreoretinal dysplasia,
microphthalmia, corneal opacity, microcornea and nystagmus.
Additional features reported in one of the families include
congenital cataracts, optic nerve hypoplasia and persistent
fetal vasculature. However, it is likely that both families
have the same disorder and that the additional findings in
NE1 were not observed in MEP57 due to the limited clinical
data that was available. Our findings also support a recent
study which identified a 6.5 kb homozygous deletion of an
evolutionarily conserved remote enhancer located 20 kb up-
stream of ATOH7 in an inbred community of Kurdish
descent from Iran in which 1% of the population had non-
syndromic congenital retinal non-attachment as well as optic
nerve aplasia, nystagmus and progressive corneal opacification
(21). Although the authors used transgenic animal models with
reporter constructs to show that the enhancer was required for
ATOH7 expression, evidence that deletion of the enhancer
region caused the disease phenotype remained circumstantial.
However, the clinical features described in the Iranian patients
show substantial overlap with that of the patients described in
this study (Table 2). This study therefore provides further
support for the assertion by those authors that the enhancer
deletion is pathogenic in those patients. Furthermore, a locus
for autosomal recessive persistent fetal vasculature has previ-
ously been mapped in a single family to a chromosomal region
overlapping ATOH7 (22). Like the patients reported in this
study, affected individuals in that family had retrolental
masses, peripheral anterior synechiae, corneal opacities and
Figure 2. Analysis of NE1. (A) Pedigree structure for family NE1. The individuals from whom DNA is available are numbered. (B) Current photos of the an-
terior segment of affected family members F475 (aged 16 years) and F476 (aged 14 years). Detailed views of the right eye of patients F475 (1) and F476 (2) as
well as the left eye of patient F476 (3) are shown. Note reduced globe size (microphthalmia), diffuse corneal haze with additional superficial, predominantly
interpalpebral, discrete opacity secondary to calcium deposition (band keratopathy). The observed ocular deviation (strabismus) is a result of the poor
vision. There are no signs associated with significant anterior segment inflammation. (C) Sequence chromatograms highlighting the ATOH7 mutation in an
affected patient from NE1 and the corresponding wild-type sequence from a normal individual. (D) Diagrammatic representation of ATOH7 (NP_660161).
The position of the bHLH domain and the mutations relative to the full-length 152 amino acid protein are shown.
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cataracts. Examination of the youngest affected subject in that
family, a 5-year-old boy, highlighted persistent fetal vasculature
and retinal folds but no detachment suggesting that the other
features are a consequence of disease progression. It therefore
seems highly likely that this family will also harbour mutations
in ATOH7. These studies highlight the varied clinical diagnoses
assigned to patients who may be suffering from the same
genetic disorder and emphasizes the need to interrogate thor-
oughly the phenotypic data presented in each case rather than
focus on the label given at initial diagnosis.
Many of the ocular features for both the anterior and poster-
ior segment described above in patients with ATOH7 muta-
tions are also found in severe FEVR, osteoporosis
pseudoglioma syndrome and Norrie disease (23–28). A
recent study reported reduced optic nerve head size in a
cohort of FEVR patients compared with controls (29). All of
these disorders are known to be caused by mutations in
genes which encode components of a signalling complex
which activates the Norrin/b-catenin signalling pathway
(30–32). This pathway is similar to the Wnt/b-catenin signal-
ling pathway with the exception that the Wnt ligand is
replaced by Norrin. Studies in human patients and mouse
models have shown that the primary ocular defect in these
disorders is insufficient development of the retinal vasculature
(25,33–38), although dysgenesis of the ganglion cell layer was
also noted in the Norrin knockout mouse (39). It is interesting
to note that although Atoh7-deficient mice lack optic nerves
and have a drastic reduction in ganglion cell abundance,
they also have ectopic blood vessels within the posterior
chamber that could represent persistent hyaloid vessels or
reflect choroidal neovascularization, although a detailed exam-
ination of the vasculature in these mice was not performed (7).
In addition to its role in the development of the retinal vascu-
lature, Wnt signalling has also been shown to play a key role
in the regression of the hyaloid vasculature. Wnt7b secreted by
macrophages in the eye activates Wnt signalling in vascular
endothelial cells to initiate cell death and hyaloid regression
(40). This regression of the hyaloid vasculature precedes the
development of the retinal vasculature, although the precise
mechanism of this interaction is not known yet.
The main differences between the pathologies of the Atoh7-
deficient mice and human patients with homozygous ATOH7
mutations described in this study are that the mice failed to
demonstrate complete retinal detachment and any obvious
anterior segment abnormalities were absent (7,8). The dispar-
ity in retinal detachment between both species most likely
Table 2. Comparison of the clinical features of patients with homozygous ATOH7 mutations
MEP57 (c.146A.T, p.E49V) NE1 (c.53delC, p.P18RfsX69) Ghiasvand et al.21 (6.5 kb
deletion of ATOH7
enhancer)
2298 2299 2301 2303 F475 F476
Age 33 24 ? ? 10 8 3–49
Cornea
Corneal diameter Small^ Small^ Small^ Small^ Small^ Small^ Small^
Opacity c.p c.p c.p c.p c.p c.p c.p
Secondary band
keratopathy
2 2 2 2 + + ?
Globe
Microphthalmia
OD/OS (mm)
10/12 8/7 ++^ ++^ 15/10 +^ ?
Iris
Irido-corneal
adhesion
p p p p 2 2 +
Iris coloboma 2 2 2 2 2 2 2
Irido-lenticular
adhesions
2 2 2 2 2 2 2
Iris hypoplasia 2 2 2 2 2 2 2
Lens
Kerato-lenticular
touch
2 2 2 2 2 2 2
Cataract ? ? ? ? + + 2
Vitreous
Vitreousa Multifocal dot,
retrolental mass
Multifocal dot,
retrolental mass
? ? Linear opacity,
retrolental mass
Linear opacity,
retrolental mass
Linear opacity, retrolental
mass
Retina
Detacheda ++ ++ ? ? ++ ++ ++
Optic nerve
Sizea ? ? ? ? Small^ Small^ Absent/small^
Function
Nystagmus + + + + + + +
Vision NPL/NPL NPL/NPL PL/PL PL/PL PL/PL PL/PL NPL/NPL
All patients in families MEP57 and NE1 as well as the general features of the Iranian patients that were recently reported by Ghiasvand et al. (21) are depicted. The
meanings of the symbols used in the table are as follows; ^, exact measurement unavailable; c, central; p, peripheral; 2, absent; +, present; ++, present in a
severe form; ?, unknown; PL, perception of light; NPL, no perception of light.
aThe descriptions for vitreous, retina and optic nerve were based on ultrasound or orbital MRI measurements.
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reflects differences between the relative volume of the lens
and vitreous chamber, the retinal architecture and timing of
neuronal and vascular development. The anterior segment
discrepancies reflect the dissimilarities in the posterior
segment, which show a milder phenotype in the mutant
mice. Nevertheless, it is interesting to note that dominant
mutations in the master eye control gene PAX6 (paired box
6), which is an upstream regulator of ATOH7 (6,41), also
causes both anterior segment and retinal abnormalities
(42,43). However, unlike ATOH7 which is restricted to
developing neuronal cells and is required for RGC develop-
ment (6–10), PAX6 is not only involved in mediating
retinal progenitor cell fate (44) but also has a role in very
early development in the migration of neural crest cells to
form the lens placode (45,46). Our data on the human
ATOH7 mutant phenotype extends the primarily retinal obser-
vations noted previously to include both anterior segment and
vascular abnormalities. Despite these observations, given that
retinal neurogenesis precedes the development of the vascula-
ture during early development (47–50) and the previously
reported findings in transgenic animal models (7–9), it is
likely that the absence of RGCs may be the primary cause
of disease pathogenesis in the patients described in this study.
In summary, we have identified homozygous mutations in
ATOH7 as a cause of global eye developmental defects in
human patients. This finding will benefit patients with
ATOH7 mutations and their families by facilitating accurate
diagnosis and counselling as well as help in the development
of future therapies. Furthermore, in addition to the established
function of ATOH7 in retinal progenitor cell specification,
these findings reveal wider roles in the regression of the
hyaloid vasculature, the development of the retinal vasculature
as well as the anterior segment structures of the eye.
MATERIALS AND METHODS
Subjects
This study was performed using a process approved by the
Pakistan Medical Foundation in Lahore and the Leeds Teach-
ing Hospitals Trust Research Ethics Committee. Informed
consent was obtained from all participants in accordance
with the tenets of the Declaration of Helsinki. Clinical exam-
ination involved a detailed eye inspection and ultrasound
examination in selected patients. In addition, affected
members of NE1 underwent orbital MRI and cranial CT
imaging. Peripheral blood was taken from available family
members and genomic DNA was extracted according to stand-
ard procedures. Control subjects were normal individuals who
were recruited as siblings of patients subject to genetic testing.
None of the families involved had any member with an inher-
ited eye abnormality and all the individuals were of Asian sub-
continent extraction.
Autozygosity mapping
DNA from the affected individuals was genotyped using SNP
arrays (Affymetrix 6.0, AROS Applied Biotechnologies,
Aarhus, Denmark) and regions of homozygosity highlighted
using IBD finder software as described before (51). Linkage was
confirmed using polymorphic microsatellite markers on a
genetic analyser according to the manufacturer’s instructions
(3130xl Genetic Analyser, Applied Biosystems, Warrington, UK).
Next generation sequencing
A customized liquid-phase ‘SureSelect Target Enrichment’
biotinylated cRNA bait was designed using the Agilent
Technologies eArray platform (Agilent Technologies Ltd.,
Edinburgh, UK). This reagent was designed against all the
UCSC Genome Browser coding exons and flanking 20 bp
from the known genes within the critical interval. Three
micrograms of patient DNA was sheared by sonication and
ligated onto adaptors using standard procedures. This
mixture was hybridized against the customized baits and
eluted to capture the enriched DNA library which was
sequenced for 80 bp single-end reads on a single lane of the
Illumina Genome Analyzer GAIIx (Illumina Inc., CA, USA).
The raw data files were processed by the Illumina pipeline
(version 1.3.4) and the sequencing reads were aligned to the
human reference sequence (hg19/GRCh37) with Novoalign
software (Novocraft Technologies, Selangor, Malaysia).
Alignments were processed in the SAM/BAM format (52)
using Picard and The Genome Analysis Toolkit (GATK)
(53) java programs in order to correct alignments around
indel sites and mark and remove potential PCR duplicates.
Variants for the coding regions were reported in the VCF
format using the Unified Genotyper and DINDEL (54) func-
tions of GATK, before filtering against variants recorded in
dbSNP131.
Direct DNA sequencing
Primers for the amplification of ATOH7, PBLD and FRMPD2
are depicted in Supplementary Material, Table S1. For all
primers pairs, amplification was performed using HotShot
Diamond PCRTM mastermix according to the manufacturer’s
instructions (Clent Life Science, Stourbridge, UK). PCR pro-
ducts were digested using ExoSAP-IT (USB Corporation,
Cleveland, OH, USA) and sequenced using the Big Dye ter-
minator cycle sequencing Kit v.3.1 (Applied Biosystems) on
the ABI 3130XL DNA analyser (Applied Biosystems). The
results were analysed using SeqScape version 2.5 software
(Applied Biosystems).
Bioinformatic analysis
For the prediction of the impact of an amino acid substitution
on the structure and function of a protein, PolyPhen-2 (Poly-
morphism Phenotyping v.2) scores were calculated at
http://genetics.bwh.harvard.edu/pph2/ under a HumVar
model (55). For evolutionary conservation, the protein
sequences were downloaded from the NCBI (http://www.
ncbi.nlm.nih.gov/protein) and the alignments calculated
using ClustalW (http://www.ebi.ac.uk/clustalw2/).
Protein modelling
The structural model of the mutant and wild-type bHLH
domain of human ATOH7 (accession number NP_660161)
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was derived by homology modelling using the M4T server
(56,57). The crystal structure of the mouse Neurogenic differ-
entiation factor 1 bound to DNA (PDB code 2ql2), which
shares 61% sequence identity to the bHLH domain of
human ATOH7, was used as template. The quality and stereo-
chemistry of the model was assessed using ProSA-II (https://
prosa.services.came.sbg.ac.at/prosa.php) and PROCHECK
(http://www.ebi.ac.uk/thornton-srv/software/PROCHECK/),
respectively, and the figures were generated using PYMOL
(http://pymol.sourceforge.net/).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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